Gland Pharma Limited — Others, 28-03-2025: Trading Window

Gland Pharma has announced a board meeting to consider and approve the audited financial results for the quarter and financial year ending on March 31, 2025. In the meantime, the trading window for the company's securities will be closed from March 29, 2025, until 48 hours after the results are declared. This strategic decision is likely aimed at maintaining compliance with insider trading regulations and protecting shareholder interests. Investors should monitor this development, as the upcoming results could influence market sentiment, presenting both potential opportunities and risks.